Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.708 | 0.520 | 19 | 44919689 | downstream gene variant | A/G | snv | 0.18 |
|
Nervous System Diseases; Mental Disorders | 0.820 | 1.000 | 11 | 2007 | 2019 | |||||||
|
0.708 | 0.520 | 19 | 44919689 | downstream gene variant | A/G | snv | 0.18 |
|
Cardiovascular Diseases | 0.820 | 1.000 | 4 | 2009 | 2016 | |||||||
|
0.708 | 0.520 | 19 | 44919689 | downstream gene variant | A/G | snv | 0.18 |
|
Eye Diseases | 0.810 | 1.000 | 2 | 2013 | 2019 | |||||||
|
0.708 | 0.520 | 19 | 44919689 | downstream gene variant | A/G | snv | 0.18 |
|
0.800 | 1.000 | 16 | 2007 | 2019 | ||||||||
|
0.708 | 0.520 | 19 | 44919689 | downstream gene variant | A/G | snv | 0.18 |
|
0.800 | 1.000 | 8 | 2009 | 2018 | ||||||||
|
0.708 | 0.520 | 19 | 44919689 | downstream gene variant | A/G | snv | 0.18 |
|
0.800 | 1.000 | 7 | 2010 | 2019 | ||||||||
|
0.708 | 0.520 | 19 | 44919689 | downstream gene variant | A/G | snv | 0.18 |
|
0.800 | 1.000 | 7 | 2009 | 2019 | ||||||||
|
19 | 44919330 | 3 prime UTR variant | A/G | snv | 3.7E-02 |
|
0.800 | 1.000 | 6 | 2012 | 2019 | ||||||||||
|
0.708 | 0.520 | 19 | 44919689 | downstream gene variant | A/G | snv | 0.18 |
|
0.800 | 1.000 | 5 | 2007 | 2018 | ||||||||
|
19 | 44919330 | 3 prime UTR variant | A/G | snv | 3.7E-02 |
|
0.800 | 1.000 | 3 | 2012 | 2019 | ||||||||||
|
0.882 | 0.080 | 19 | 44912383 | non coding transcript exon variant | G/A;C | snv |
|
0.800 | 1.000 | 3 | 2011 | 2017 | |||||||||
|
0.708 | 0.520 | 19 | 44919689 | downstream gene variant | A/G | snv | 0.18 |
|
0.800 | 1.000 | 2 | 2011 | 2014 | ||||||||
|
0.882 | 0.080 | 19 | 44912383 | non coding transcript exon variant | G/A;C | snv |
|
Cardiovascular Diseases | 0.800 | 1.000 | 1 | 2011 | 2011 | ||||||||
|
0.708 | 0.520 | 19 | 44919689 | downstream gene variant | A/G | snv | 0.18 |
|
Cardiovascular Diseases | 0.720 | 1.000 | 3 | 2009 | 2015 | |||||||
|
0.925 | 0.160 | 19 | 44919589 | downstream gene variant | G/A | snv | 0.18 |
|
Nervous System Diseases; Mental Disorders | 0.710 | 1.000 | 4 | 2014 | 2019 | |||||||
|
0.708 | 0.520 | 19 | 44919689 | downstream gene variant | A/G | snv | 0.18 |
|
Mental Disorders | 0.710 | 1.000 | 2 | 2012 | 2019 | |||||||
|
0.708 | 0.520 | 19 | 44919689 | downstream gene variant | A/G | snv | 0.18 |
|
Endocrine System Diseases | 0.710 | 1.000 | 2 | 2013 | 2016 | |||||||
|
0.708 | 0.520 | 19 | 44919689 | downstream gene variant | A/G | snv | 0.18 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.710 | 1.000 | 2 | 2013 | 2016 | |||||||
|
0.708 | 0.520 | 19 | 44919689 | downstream gene variant | A/G | snv | 0.18 |
|
0.700 | 1.000 | 10 | 2008 | 2013 | ||||||||
|
19 | 44917997 | intron variant | G/A | snv | 0.11 |
|
0.700 | 1.000 | 2 | 2012 | 2012 | ||||||||||
|
19 | 44917997 | intron variant | G/A | snv | 0.11 |
|
0.700 | 1.000 | 2 | 2012 | 2012 | ||||||||||
|
19 | 44917997 | intron variant | G/A | snv | 0.11 |
|
0.700 | 1.000 | 2 | 2012 | 2012 | ||||||||||
|
19 | 44917997 | intron variant | G/A | snv | 0.11 |
|
0.700 | 1.000 | 2 | 2012 | 2012 | ||||||||||
|
19 | 44917086 | intron variant | G/A | snv | 7.9E-02 |
|
0.700 | 1.000 | 2 | 2012 | 2012 | ||||||||||
|
19 | 44917086 | intron variant | G/A | snv | 7.9E-02 |
|
0.700 | 1.000 | 2 | 2012 | 2012 |